Psychosomatics
-
A recent series of case reports has demonstrated a significant, previously unrecognized drug interaction between serotonin reuptake inhibitors (SRIs) and methylene blue (MB). ⋯ SRIs can interact with MB, causing a serious adverse reaction consistent with serotonin syndrome.